CERo Therapeutics Stock (NASDAQ:CERO)


Chart

Previous Close

$0.43

52W Range

$0.40 - $98.60

50D Avg

$0.67

200D Avg

$6.08

Market Cap

$3.51M

Avg Vol (3M)

$2.00M

Beta

0.68

Div Yield

-

CERO Company Profile


CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

8

IPO Date

Nov 30, 2021

Website

CERO Performance